Hong Kong Med J 2014;20(Suppl 6):S32-4
Use of serum hepatitis B viral DNA in prognostication of patients undergoing non- surgical therapy for liver cancer
SL Chan, FKF Mo, PKS Chan, W Yeo
Department of Clinical Oncology, The Chinese University of Hong Kong
1. Hepatitis B virus (HBV) load is not a prognostic factor for patients with advanced HBV-related hepatocellular carcinoma (HCC) undergoing non-surgical therapy.
2. Antiviral therapy for HBV-related HCC is associated with improved survival outcome.
2. Antiviral therapy for HBV-related HCC is associated with improved survival outcome.